Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02342379 |
Title | TH-302 in Combination With Bevacizumab for Glioblastoma |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | The University of Texas Health Science Center at San Antonio |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Dana-Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center | San Antonio | Texas | 78229 | United States | Details |